YAP1 and small cell lung carcinoma: Consistent with this notion, rare RB1-proficient SCLC tumors exhibit relatively lower neuroendocrine marker expression and are enriched for YAP1, implying that YAP1-driven tumors may arise in cases where RB1 loss is incomplete or functionally compensated [38].